FilingIndex
AGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-KAGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-K
← TNXP · Tonix Pharmaceuticals Holding Corp.
8-KThe WireRoutine

Reg FD Disclosure · Company Update

Filed Jul 16, 2025 · 11mo ago · Accession 0001999371-25-009199

Plain English

Material event — a significant development the company must disclose promptly.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Company
Tonix Pharmaceuticals Holding Corp.
Ticker
TNXP
CIK
1430306
Form type
8-K
Filing date
Jul 16, 2025
Report date
Jul 16, 2025
Document
tnxp-8k_071625.htm
Size
10.1 MB

More from TNXP

8-KReg FD Disclosure · Company UpdateJun 29, 20268-KReg FD Disclosure · Company UpdateJun 8, 20268-KReg FD Disclosure · Company UpdateMay 27, 20268-KReg FD Disclosure · Company UpdateMay 15, 202610-QQUARTERLY REPORTMay 11, 20268-KResults of OperationsMay 11, 2026